BMEA down 15.4% on Oct 13 2026 with no filing that explains it
BMEA-15.4%on Tue Oct 13 2026
Biomea Fusion, Inc. Common Stock was down 15.4% on the day at $1.15, ranked #4 on 262× its usual five-minute volume, when TapeRank recorded this unexplained move at 16:09 ET during after hours. TapeRank recorded 2 events for BMEA that day, between 16:09 and 16:19 ET, and each is in the timeline below.
THE DAY ON THE LIST · 2 EVENTS
- 16:09 ETUNEXPLAINED MOVE · AFTER-HOURS
$1.15 · ▼ 15.4% ON THE DAY · 262× 5M RVOL · RANK #4
UNEXPLAINEDCONFIDENCE4/5BMEA fell 13.4% on the day and accelerated nearly 10% in five minutes after hours. The supplied news only announces upcoming Phase I BMF-650 results and provides no actual results or negative update, so order flow is driving the move.
WHYA 13.4% decline, including a 9.98% five-minute drop, is not explained by an announcement merely scheduling clinical results without disclosing data.ANALYZED 16:09 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 16:09 ET
LAST1.15DAY▼ 15.4%5 MIN▼ 12.11%5M RVOL262×5M $VOL$149KFLOAT*72.5MRANK#4SESSIONAFTER-HOURSVWAP1.33HOD1.52LOD1.00OR HIGH1.44OR LOW1.40PREV CLOSE1.36PM HIGH1.52PM LOW1.40GAP▲ 5.51%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
- 16:19 ETMOVER · AFTER-HOURS
$0.9400 · ▼ 30.9% ON THE DAY · 123× 5M RVOL · RANK #1
STRETCHEDCONFIDENCE4/5BMEA fell 26.4% to $1.00, including another 9.0% in the last five minutes, after reporting early Phase 1 BMF-650 data. The data showed only 1.5% to 3.2% mean weight loss at Day 29 with small cohorts, so the severe selloff is larger than the disclosed clinical update alone supports.
WHYDown 26.4% on modest, early Phase 1 weight-loss data with no serious safety signal is a much larger move than the news itself warrants.ANALYZED 16:15 ET · 3 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 16:19 ET
LAST0.9400DAY▼ 30.9%5 MIN▼ 12.15%5M RVOL123×5M $VOL$507KFLOAT*72.5MRANK#1SESSIONAFTER-HOURSVWAP1.28HOD1.52LOD0.8700OR HIGH1.44OR LOW1.40PREV CLOSE1.36PM HIGH1.52PM LOW1.40GAP▲ 5.51%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $1.44, +5.5% on the previous close of $1.36
- 09:31 ETRegular-session high, $1.44
- 10:52 ETRegular-session low, $1.23
- 15:59 ETLast trade of the regular session, $1.25, -7.7% on the previous close of $1.36
- Volume: 4.3M shares in regular hours, 391K before the open
BMEA opened at $1.44, briefly held that level, then fell to a $1.23 low by 10:52 ET before ending regular trading at $1.25, with no halts. After hours, the decline accelerated, reaching $1.15 at 16:09 ET and $0.9400 at 16:19 ET, the session’s largest recorded move. TapeRank initially found the move unexplained because the earlier news only scheduled Phase I BMF-650 results without disclosing data; after the 16:10 ET report, it tied the selloff to early results showing 1.5% to 3.2% mean weight loss at Day 29 in small cohorts, while reading the decline as stretched relative to that update.
WRITTEN THU OCT 15 2026 18:04 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 16:10 ETBiomea Fusion Reports Phase 1 Results For Oral GLP-1 Candidate BMF-650, Showing Consistent Weight Reduction And Encouraging TolerabilityBenzinga
- 02:59 ETBiomea Fusion Stock Climbs 7% After-Hours: What's Going On?Benzinga
- MON 16:32 ETBiomea Fusion To Report Results From Phase I GLP-131 Clinical Study Evaluating BMF-650, Investigational Next-Gen Oral Small-Molecule GLP-1 Receptor Agonist, On October 13Benzinga
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list